Free tool
FAERS Monitor: Lithostat
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018749 or its brand name (Lithostat, Acetohydroxamic Acid). Reports on generic versions are filed under their own applications.
Reports
47
Serious
11
23% of reports
Hospitalization
6
Death reported
5
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache12
- decreased appetite10
- tremor9
- asthenia5
- nausea5
- confusional state4
- death4
- fatigue4
- rash4
- somnolence4
- abdominal pain upper3
- alopecia3
- diarrhoea3
- dizziness3
- feeling abnormal3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 2 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 13 |
| 2018 | 12 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 6 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,112 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| tremorSignal | 9 | 24.3 | 13.5 | 180 |
| decreased appetiteSignal | 10 | 19.3 | 11.1 | 157 |
| confusional stateSignal | 4 | 11.1 | 4.3 | 27 |
| somnolenceSignal | 4 | 8.9 | 3.5 | 21 |
| headacheSignal | 12 | 8.6 | 5.3 | 75 |
| alopeciaSignal | 3 | 6.8 | 2.3 | 10 |
| abdominal pain upperSignal | 3 | 6.5 | 2.2 | 9 |
| astheniaSignal | 5 | 6.0 | 2.6 | 16 |
| feeling abnormalSignal | 3 | 5.6 | 1.9 | 7 |
| rashSignal | 4 | 4.1 | 1.6 | 7 |
| nauseaSignal | 5 | 2.8 | 1.2 | 4 |
| dizziness | 3 | 2.7 | 0.9 | 2 |
| fatigue | 4 | 2.3 | 0.9 | 2 |
| diarrhoea | 3 | 2.1 | 0.7 | 1 |
| death | 4 | 2.1 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.